| Agency |
Title |
Period |
| EU |
Marine Microbial Biodiversity, Bioinformatics and Biotechnology (MICRO B3) |
2012-2016 |
| EU |
Marine Microorganisms: Cultivation Methods for improving their Biotechnological Applications (MACUMBA) |
2012-2016 |
| EU |
Increasing Value and Flow in the Marine Biodiscovery Pipeline (PharmaSea) |
2012-2016 |
| IRCSET |
Understanding the molecular mechanism through which aspirated bile triggers chronic P. aeruginosa infections in respiratory disease. |
2014-2018 |
| SFI Tida 2014 |
Next Generation Antibiotics: anti-biofilm, anti-pathogenic natural bioactives from marine microorganisms. |
2015-2016 |
| DAFF |
Marine Institute (Beaufort) 'Marine Biodiscovery/Biotechnology |
2007-2015 |
| EU INMARE |
Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea |
2015-2018 |
| O'Brien Fine Foods |
Microbial diversity and abundance analysis in process cover brine. |
2014-2016 |
| FIRM ( Dept Ag/Marine) |
Use of Marine derived Antibacterial agents to combat Salmonella in Pork Products. |
Aug 2013-2016 |
| SFI National Centres . |
Synthesis and Solid State Pharmaceutical Centre |
June 2013 –2019 |
| Eu - Madam Curie ITN |
Blue Pharma |
Sept 2013— 2017 |
| Teagasc Walsh Fellowship |
The use of marine derived antibacterial agents to combat the prevalence of Salmonella in pork products |
Oct 2013 - Sep 2017 |
| FIRM ( Dept Ag/Marine) |
The anti-inflammatory and Microbial modulatory effects of marine derived Laminarin and omega 3 fatty acid on inflammatory bowel disease in an expimental porcine model |
2014-2018 |
| Irish T.S. |
Investigate the impact of bile aspiration on chronic respiratory desease: Chronic infection - Bile Paradigm |
2014-2016 |
